The “Guidelines for Renal Anemia in Chronic Kidney Disease” of the Japanese Society for Dialysis Therapy (JSDT) set an Hb target of 11–13 g/dL for NDCKD patients [14], which is higher than that in guidelines published in other countries. This evidence concerns the gene GSTM1 and chronic kidney disease.